Viking Therapeutics (VKTX) Misses Q4 EPS by 12c

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.56), $0.12 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
• Kraken Robotics closes $615M Covelya acquisition, raises 2026 outlook